Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Integer Holdings ( (ITGR) ) just unveiled an announcement.
On November 3, 2025, Integer Holdings Corporation’s Board of Directors approved a share repurchase program allowing the company to buy back up to $200 million of its common stock. This initiative, announced on November 4, 2025, reflects the Board’s confidence in the company’s strategy and financial health, intending to use cash on hand and free cash flows for the repurchases. The program’s flexible nature allows management to execute repurchases opportunistically, potentially impacting the company’s stock value and shareholder returns positively.
The most recent analyst rating on (ITGR) stock is a Hold with a $69.00 price target. To see the full list of analyst forecasts on Integer Holdings stock, see the ITGR Stock Forecast page.
Spark’s Take on ITGR Stock
According to Spark, TipRanks’ AI Analyst, ITGR is a Neutral.
Integer Holdings’ overall stock score reflects strong financial performance and cash flow generation, but is tempered by bearish technical indicators and valuation concerns. The recent earnings call highlighted both strong past performance and future challenges, impacting the outlook.
To see Spark’s full report on ITGR stock, click here.
More about Integer Holdings
Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations in the world, serving markets such as cardiac rhythm management, neuromodulation, and cardio and vascular. The company acts as a strategic partner to medical device companies and OEMs, providing innovative and high-quality products and solutions. Its brands include Greatbatch Medical and Lake Region Medical.
Average Trading Volume: 816,307
Technical Sentiment Signal: Sell
Current Market Cap: $2.35B
Learn more about ITGR stock on TipRanks’ Stock Analysis page.

